Bharat Immunological & Biological Corporation reports standalone net loss of Rs 1.98 crore in the June 2017 quarter

Capital Market 

Sales decline 87.95% to Rs 3.35 crore

Net Loss of Immunological & Biological Corporation reported to Rs 1.98 crore in the quarter ended June 2017 as against net loss of Rs 0.38 crore during the previous quarter ended June 2016. Sales declined 87.95% to Rs 3.35 crore in the quarter ended June 2017 as against Rs 27.79 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales3.3527.79 -88 OPM %-61.19-1.80 -PBDT-1.78-0.36 -394 PBT-1.92-0.53 -262 NP-1.98-0.38 -421

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)